| Stage | CSCO | % of rev | ATEN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.3B | 100.00% | $80M | 100.00% | CSCO ×215.28 |
| Gross profit | $11.1B | 64.13% | $63M | 79.09% | ATEN +15.0pp |
| Operating income | $4.3B | 24.72% | $9M | 11.26% | CSCO +13.5pp |
| Pre-tax income | $4.9B | 28.59% | $10M | 12.38% | CSCO +16.2pp |
| Net income | $3.9B | 22.37% | $9M | 11.08% | CSCO +11.3pp |
| Stage | CSCO | ATEN | Gap · A − B |
|---|---|---|---|
| Revenue | $17.3B100.00% | $80M100.00% | CSCO ×215.28 |
| Gross profit | 64.13%$11.1B | 79.09%$63M | ATEN +15.0pp |
| Operating income | 24.72%$4.3B | 11.26%$9M | CSCO +13.5pp |
| Pre-tax income | 28.59%$4.9B | 12.38%$10M | CSCO +16.2pp |
| Net income |
| 22.37%$3.9B |
| 11.08%$9M |
| CSCO +11.3pp |
No shared counterparties.